156 results
Page 3 of 8
8-K
EX-99.2
mnbywmxw
24 Mar 20
Other Events
8:32am
424B5
uxuo wkgs7bn
21 Feb 20
Prospectus supplement for primary offering
7:02am
8-K
EX-10.1
uqgkexutng2u
20 Feb 20
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-14.1
sv5 s8u9io
18 Dec 19
Departure of Directors or Certain Officers
4:23pm
8-K
EX-10.2
huyqz6f27a450l13
18 Dec 19
Departure of Directors or Certain Officers
4:23pm
8-K
EX-99.1
d50 e85whmsw
4 Dec 19
Ampio Provides Update on AP-013 Phase III Clinical Trial and Annual Meeting Conference Call Number
8:44am
8-K
EX-99.1
7ykv4pgqkty
10 Oct 19
Ampio Provides Update on Continued Progress of AP-013 Phase III Clinical Trial and Manufacturing Facility
4:01pm
8-K
EX-99.1
gghny1if
20 Sep 19
Departure of Directors or Certain Officers
4:02pm
8-K
EX-10.1
kronnj2jo9v xaa4
20 Sep 19
Departure of Directors or Certain Officers
4:02pm
8-K
EX-99.2
5r8z9nqg
20 Sep 19
Departure of Directors or Certain Officers
4:02pm
8-K
EX-10.1
r9xxv qa2
10 Jul 19
Ampio Appoints Dan Stokely as the Company’s new Chief Financial Officer
4:02pm
8-K
EX-99.1
rmd5a
19 Jun 19
Ampio Pharmaceuticals Announces Closing of $12 Million Public Offering
4:01pm
8-K
EX-10.2
puzrh6s0619fui7m
17 Jun 19
Ampio Pharmaceuticals Announces Pricing of Public Offering
9:23am
8-K
EX-10.1
fbjgg aw3zjktiu
17 Jun 19
Ampio Pharmaceuticals Announces Pricing of Public Offering
9:23am